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Background: Preoperative glucocorticoid (GC) administration attenuates the physiological response to
surgery and improves clinical outcomes. However, GC use is not yet universally implemented. A
propensity score analysis was performed to evaluate preoperative GC use in elective colectomy.
Methods: A retrospective review of prospectively collected data was conducted for all patients who had
undergone elective colectomy within an established Enhanced Recovery After Surgery (ERAS) pro-
gramme at our institution from January 2006 to 2010. Demographic data, surgery type, glucocorticoid
administration and clinical outcomes including complication rates and length of hospital stay (LOS) were
investigated. Univariate and propensity score analyses were conducted with statistical signiﬁcance
identiﬁed as p  0.05.
Results: There were 253 patients included in the analysis, of which 146 received preoperative GC. There
were signiﬁcant baseline differences between those who received GC and those who did not in male
gender (GC: 56 (38%); non-GC: 58 (54%); p ¼ 0.02) and American Society of Anesthesiologists (ASA) III
(GC: 40 (27%); non-GC: 43 (40%); p ¼ 0.04). On univariate analysis, there were no signiﬁcant differences
in the incidence of total complications, major complication, anastomotic leak and infectious complica-
tion. On propensity score analysis, preoperative GC administration was found to be independently
associated with a reduction in LOS (GC: 5; Non-GC: 6; p ¼ 0.04).
Conclusion: Preoperative GC administration is associated with a reduction in LOS without an increase in
postoperative complications.
 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Major abdominal surgery leads to a signiﬁcant physiological
inﬂammatory response.1e3 This is characterised by local and
systemic release of biologically redundant, pro-inﬂammatory
cytokines, such as interleukin (IL) 6, IL-1b and tumour necrosis
factor (TNF) a.4,5 The subsequent clinical result of this physiological
insult is increased postoperative morbidity, prolonged convales-
cence and overall impaired surgical recovery.6
An empiric approach to this inﬂammation is the preoperative
administration of glucocorticoids (GC).7 When given as a single
intravenous dose approximately 90 min prior to anaesthetic
induction, to counter biological redundancy, GC has been shown to
effectively attenuate surgically induced inﬂammation.8 The result isAuckland Clinical School,
u, Auckland, New Zealand.
(D. Lemanu).
ciates Ltd. Published by Elsevier Lta decrease in postoperative morbidity and length of postoperative
hospital stay (LOS).9
Although the use of GC is supported by the results of a recent
systematic review and meta-analysis,9 their use has yet to become
accepted as standard of practice. It is important therefore to
continue to prospectively evaluate and publish long term outcomes
in line with the IDEAL recommendations.10e12 We have therefore
performed a review of data to evaluate the efﬁcacy and safety of
preoperative GC use in patients undergoing elective colectomy
within an Enhanced Recovery After Surgery (ERAS) Programme.2. Methods
A retrospective review of prospectively collected data was performed of all
patients who had undergone elective colectomy within an established ERAS pro-
gramme between January 2006 and 2010 which has been described previously.13
The use of preoperative GC became a routine component of the ERAS programme
in 2008 following the results of a randomised controlled trial performed at our
institution during this time.5 Patients were excluded if they had rectal resection,
were ASA IV or more, required a stoma, were on long term corticosteroid therapy, or
had intellectual impairment and were therefore unable to participate in an ERASd. All rights reserved.
Table 2
Baseline characteristics.
Variable GC (n ¼ 146) Non-GC (n ¼ 107) p Value
Age, mean (SD) 66 (15) 69 (14) 0.08b
Males (%) 56 (38) 58 (54) 0.02a
Left sided cases (%) 60 (41) 44 (41) 1.00a
Laparoscopic cases (%) 18 (12%) 12 (11%) 0.85a
ASA score I (%) 25 (17) 16 (15) 0.73a
ASA score II (%) 81 (55) 48 (45) 0.10a
ASA score III (%) 40 (27) 43 (40) 0.04a
Cr-POSSUM, mean (SD) 17 (3) 17 (3) 0.83b
GC ¼ glucocorticoid.
SD ¼ standard deviation.
ASA ¼ American society of anesthesiologists score.
a Fisher’s exact test.
b t-Test.
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ister GC or the perioperative care provided within the ERAS programme. The
patients were stratiﬁed according to whether or not they had received GC in the
form of eight milligrams of intravenous dexamethasone (Dexamethasone Sodium
Phosphate Injection, 8 mg/ml; Hospira, Wellington, New Zealand), at the time of
anaesthetic induction.
2.1. Preoperative characteristics
The baseline demographic data recorded by the authors were age, gender,
American Society of Anesthesiologists (ASA) score, Cr-POSSUM score and type of
surgery.
2.2. Outcome measures
The outcome measures of interest were total complication and major compli-
cation rates. Complications were prospectively recorded and graded according to the
Clavien-Dindo Classiﬁcation system.14,15 The complications were deﬁned as per
Buzby et al.16 Major complications were considered grade three or higher. The
incidences of anastomotic leak and infectious complications were speciﬁcally
recorded and analysed. Infectious complications included wound infection, urinary
tract infection, respiratory infection and intra-abdominal collection. The LOS was
also recorded and analysed within the context of established discharge criteria
enforced as part of an ERAS programme implemented in 2005.
2.3. Statistical analysis
Statistical analysis was performed using SPSS (SPSS V13 Inc, Irvine CA).
Continuous variable parametricity was tested using the ShapiroeWilk test. The
groups were compared using the Two-tailed Fisher’s exact test for categorical
variables, the t-test for parametric continuous variables and the ManneWhitney U
test for non-parametric continuous variables. Univariate analysis was conducted and
a propensity score analysis was performed to control for known potential
confounders. Statistical signiﬁcance was identiﬁed as p  0.05.
2.4. Propensity score analysis
Propensity score analysis is increasingly used as an alternative to multivariable
analysis of non-randomised data. It generates a propensity score which represents
the probability that a patient would have received an intervention based on known
confounding variables.17 Propensity scores were generated for each patient using
a binary logistic regression model where the administration of GC was used as the
primary predictor variable. The observed baseline characteristics identiﬁed as
potential confounders and used in the regression model as covariates are detailed in
Table 1.
The authors utilised the analytical technique of matching by propensity score.
Univariate analysis was undertaken to compare the baseline characteristics between
the two matched groups in order to ensure the accuracy of our regression model in
calculating the propensity scores. Further univariate analysis was then undertaken
to assess the outcomes of interest as described previously.
3. Results
3.1. Baseline characteristics
There were 253 consecutive patients included in our analysis, of
which 146 patients received GC. Comparison of baseline charac-
teristics is summarised in Table 2. The two groups were unmatched
for male gender (GC: 56 (38%); non-GC: 58 (54%); p ¼ 0.02) and for
Table 1
Regression model used to generate propensity scores.
Baseline variable Odds ratio p Value
Age 0.98 0.07
Male gender 1.94 0.01a
ASA III 4.32 0.04a
ASA II 2.30 0.25
ASA I 3.02 0.17
Cr-POSSUM score 1.08 0.17
Laparoscopy 0.79 0.59
Left sided cases 1.19 0.57
The primary predictor variable used as the dependent variable was administration
of glucocorticoid at time of anaesthetic induction.
ASA ¼ American society of anesthesiologists score.
a Signiﬁcant independent association with glucocorticoid administration.the number of patients with an ASA III (GCG: 40 (27%); non-GC: 43
(40%); p ¼ 0.04).
3.2. Surgical outcomes
On univariate analysis, there was no difference between the two
groups with regard to total complication rate, major complication
rate, the incidence of anastomotic leak and the incidence of infec-
tious complication. However, in patients who received GC, there
was a signiﬁcant reduction in LOS [GC: 4 days; Non-GC: 6 days;
p ¼ <0.01] (Table 3).
3.3. Propensity score analysis
The propensity scores generated ranged from 0.25 to 0.85. Using
these scores, 156 patients were able to be matched (78 in each
group). After matching, there were found to be no differences
between the two groups in baseline characteristics (Table 4). This
helped to conﬁrm the accuracy of the regression model.
When univariate analysis of the surgical outcomes was repeated
after matching, there were found to be no differences between the
two groups in complication rates, major complication rates, the
incidence of infectious complications and the incidence of anasto-
motic leak (Table 4). However, despite the median LOS increasing
by one day in those patients who received GC, it will still found to
be signiﬁcantly less than those who did not receive GC [GC: 5 days;
non-GC: 6 days; p ¼ 0.04] (Table 4).
4. Discussion
This study has shown that in patients undergoing elective
colectomy within an ERAS programme, preoperative GC use was
independently associated with a decrease in median LOS on
univariate and propensity score analysis. Preoperative GC was not
associated with an increase in the rate of total complications, major
complications, infectious complication and anastomotic leak.Table 3
Comparison of surgical outcomes.
Outcome GC (n ¼ 146) Non-GC (n ¼ 107) p Value
Total complication (%) 60 (41) 51 (48) 0.31a
Major complication (%) 17 (11) 13 (12) 1.00a
Infectious complication (%) 23 (16) 24 (22) 0.19a
Anastomotic leak (%) 6 (4) 2 (2) 0.47a
Length of hospital stay,
median (IQR)
4 (4) 6 (5) <0.01b
IQR ¼ inter-quartile range.
ASA ¼ American society of anesthesiologists score.
a Fisher’s exact test.
b ManneWhitney U test.
Table 4
Univariate analysis of propensity matched patient subgroup.
Variable GC (n ¼ 78) Non-GC (n ¼ 778) p-Value
Mean age (SD) 67.9 (12.7) 67.1 (14.6) 0.706b
Male gender (%) 40 (51.3) 41 (52.6) 0.873a
ASA III (%) 22 (28.2) 25 (32.1) 0.601a
ASA II (%) 47 (60.3) 40 (51.3) 0.259a
ASA I (%) 9 (11.5) 13 (16.6) 0.357a
Mean Cr-POSSUM (IQR) 17.0 (3) 17.0 (4) 0.543c
Laparoscopy (%) 11 (14.1) 10 (12.8) 0.815a
Left sided cases (%) 31 (39.7) 29 (37.2) 0.742a
Total complications (%) 40 (51.3) 38 (48.7) 0.749a
Major complications (%) 11 (14.1) 13 (16.7) 0.657a
Infectious complications (%) 15 (19.2) 16 (20.5) 0.841a
Anastomotic leak (%) 5 (6.4) 2 (2.6) 0.442a
Median length of hospital
stay (IQR)
5 (5) 6 (4) 0.042c
SD ¼ standard deviation.
ASA ¼ American society of anesthesiologists score.
IQR ¼ inter-quartile range.
a Fisher’s exact test/Chi square test.
b t-Test.
c ManneWhitney U test.
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attenuate the physiological inﬂammation induced by surgery.8 A
recent systematic review and meta-analysis demonstrated this
beneﬁt by showing a signiﬁcant decrease in the rate of post-
operative morbidity in patients undergoing major abdominal
surgery.9 Speciﬁcally, in the setting of colorectal surgery, the current
literature shows that GCs have been shown to have no signiﬁcant
effect on the rate of total complication or anastomotic leak.9
The current literature also suggests that preoperative GC in
major abdominal surgery is associated with a signiﬁcant reduction
in the LOS following surgery.9 This has been demonstrated in
randomised trials in the setting of hepatic resection.18,19 GC use has
also been shown to be a predictor of successful outpatient
discharge in bariatric surgery.20 Preoperative GC are commonly
utilised as part of optimised multimodal perioperative care regimes
in colorectal surgery and, as shown by Moiniche et al., have been
associated with successful early discharge.21 There are now recent
published randomised controlled trials which suggest that GCs
have an independent effect in decreasing LOS. Vignali et al. was able
to demonstrate a signiﬁcant decrease in the mean LOS from eight
days to seven days in patients who received preoperative GC.22
Nagelschmidt et al. published similar ﬁndings with a reduction in
median LOS by 4.5 days.23
The reductions in the LOS following surgery are generally attrib-
uted to the reduction in complication rates associated with GC.9
However, this theory is not supported by this study with GC being
shown to have no independent effect on the complication rate for this
series. One theory is that this may reﬂect the attenuating effect of
preoperative GC on the intraperitoneal and systemic cytokine
cascades resulting in decreased postoperative fatigue without
a signiﬁcant reduction in the complication rate. This has been previ-
ously demonstrated in a randomised controlled trial which found
a signiﬁcant reduction in the local and systemic levels of IL-6, IL-8 and
IL-13 and signiﬁcant improvement in postoperative fatigue scores in
the absence of a signiﬁcant decrease in the complication rate.5
There are important limitations to this retrospective review.
Though accounted for in the statistical analysis, there are signiﬁcant
differences in the baseline variables of gender and ASA III between
the two groupswhichwill affect the generalisability of these results.
However, the results of this study are in concordance with higher
level evidence,9 on which the practice of our centre is based.
In summary the administration of preoperative GC is safe and
effective in elective colectomy. The ﬁndings of this study are inconcordance with the current literature. Further work to under-
stand the mechanisms of action are warranted.
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